Dr. Theresa Lamagni is a distinguished expert in infectious disease epidemiology with decades of experience shaping national public health policy in the United Kingdom. She currently serves as Section Head of the Healthcare-Associated Infection and Antimicrobial Resistance Division at the UK Health Security Agency, where she leads critical surveillance programs and research initiatives. Previously with Public Health England, Dr. Lamagni has maintained a continuous research focus on bacterial disease epidemiology since the early 1990s. Her academic credentials include a PhD and MSc, along with Honorary Membership of the Faculty of Public Health, reflecting her significant contributions to the field of infectious disease control and prevention.
Dr. Lamagni's groundbreaking work has fundamentally shaped the understanding of healthcare-associated infections and antimicrobial resistance patterns across the United Kingdom. She serves as the lead epidemiologist for streptococcal diseases at the WHO Collaborating Centre for Reference and Research, where her research has provided essential insights into invasive Group B Streptococcal disease epidemiology across all age groups since 1991. Her comprehensive analyses of national surveillance data have informed critical public health interventions and clinical guidelines for the prevention and treatment of infectious diseases. The impact of her work extends beyond academia, directly influencing national policy decisions and infection control practices in healthcare settings throughout the UK.
Beyond her research contributions, Dr. Lamagni plays a pivotal role in shaping the national response to emerging infectious disease threats through her leadership position at the UK Health Security Agency. She has established robust surveillance systems that serve as models for monitoring antimicrobial resistance trends and healthcare-associated infections across diverse healthcare settings. Dr. Lamagni regularly contributes her expertise to international collaborations through the WHO Collaborating Centre, advancing global understanding of bacterial disease epidemiology. Her ongoing work continues to address the evolving challenges of antimicrobial resistance, with a particular focus on strengthening surveillance mechanisms and translating epidemiological findings into effective public health interventions that protect vulnerable populations.
